Labiana Group, one of the global leaders in animal health industry, closed the acquisition of all issued shares in Veterinary Institute of Subotica (Vetzavod), a Serbian leading animal vaccine producer. Labiana acquired 67.05% of Vetzavod’ shares from Victoria Group AD and 32.95% from Sojaprotein AD. Labiana Group has two pharmaceuticals plants in Spain and is present worldwide with more than 400 marketing authorizations in more than 50 export markets in the AEMEA regions and Latin America.
Labiana was advised by senior partner Vladimir Dašić, partner Milan Dakić. BDK Advokati team also included associates Jelena Zelenbaba, Đorđe Zejak and Igor Matić.
